COVID-19 Impact | Malls see 77% degrowth in 1st half of June; consumer sentiment low: Report

After lockdown guidelines were relaxed in early June, most states permitted malls and high street retailers to reopen after a gap of more than 70 days.

PTI

June 21, 2020 / 13:18 IST

Representative image

Malls witnessed 77 percent degrowth while high street retail showed a decline of 61 percent in business in the first half of June, as compared to the same period last year, with consumer sentiment remaining low even after lockdown relaxations, according to a report. As per the survey conducted by the Retailers Association of India (RAI) with participation of more than 100 big and small retailers, it was found that lockdown relaxations did not benefit retailers as there was no significant surge in their business.

After lockdown guidelines were relaxed in early June, most states permitted malls and high street retailers to reopen after a gap of more than 70 days.

"However, it was found that consumer sentiment continues to be at a low. This is consistent with findings of a recent consumer survey by RAI which revealed that 4 out of 5 Indian consumers would reduce shopping expenditure post the lockdown," the retailers' body said in a statement.

The sentiment was reflected in categories like quick service restaurant (QSR) and restaurants (dip of 70 percent), followed by apparel and clothing (69 percent decline), and jewellery, watches and other personal accessories (65 percent decrease), it added.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

COVID-19 Impact | Malls see 77% degrowth in 1st half of June; consumer sentiment low: Report

After lockdown guidelines were relaxed in early June, most states permitted malls and high street retailers to reopen after a gap of more than 70 days.

Related stories

Subscribe to Tech Newsletters

COVID-19 Impact | Malls see 77% degrowth in 1st half of June; consumer sentiment low: Report

After lockdown guidelines were relaxed in early June, most states permitted malls and high street retailers to reopen after a gap of more than 70 days.

Related stories

Subscribe to Tech Newsletters

Trending news